Newsfeeds - Spark Newswire

1 minute read

News

HTG Forms New Drug Discovery Business Unit

Today, 5:55 AM

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the creation of a new business unit, HTG Therapeutics. HTG plans to use this new

HTGM

1 minute read

HTG Receives First Order For HTG Transcriptome Panel, Enters Two European EAP Agreements

By Vandana Singh

Today, 5:55 AM

HTG Molecular Diagnostics Inc (NASDAQ:HTGM) has received the first commercial orders for its planned HTG Transcriptome Panel and has signed agreements…

HTGM

2 minute read

HTG Molecular Diagnostics Receives First Commercial Orders For Planned HTG Transcriptome Panel, Signs 2 European Early Adopter Program Deals, No Terms Disclosed

By Benzinga Newsdesk

Today, 5:55 AM

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received the first commercial orders for its planned HTG Transcriptome

HTGM

2 minute read

HTG Says Completes Product Design Lock For Planned Transcriptome Panel, Announces Signing Of 3 Early Adopter Program Collaboration Agreements

By Benzinga Newsdesk

Today, 5:55 AM

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has completed product design lock for the HTG Transcriptome Panel and

HTGM

5 minute read

Uncategorized

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts

By Shanthi Rexaline

Today, 5:55 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)

ACHL

1 minute read

Uncategorized

10 Biggest Price Target Changes For Friday

By Lisa Levin

Today, 5:55 AM

Rosenblatt lowered Coinbase Global, Inc. (NASDAQ: COIN) price target from $450 to $400. Coinbase Global shares rose 2.4% to $271.46 in pre-market trading.

ABNB

1 minute read

Uncategorized

SVB Leerink Maintains Outperform on HTG Molecular Diagnostics, Lowers Price Target to $10

By Benzinga Newsdesk

Today, 5:55 AM

SVB Leerink analyst Puneet Souda maintains HTG Molecular Diagnostics (NASDAQ:HTGM) with a Outperform and lowers the price target from $15 to $10.

HTGM

14 minute read

Uncategorized

Earnings Scheduled For May 13, 2021

By Benzinga Insights

Today, 5:55 AM

Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.

AACG

7 minute read

Uncategorized

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron

By Shanthi Rexaline

Today, 5:55 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)

ABIO

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

By Shanthi Rexaline

Today, 5:55 AM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.

ABCL